Prof. Nigel Bundred is Professor of Surgical Oncology, University of Manchester and Consultant Surgeon at the University Hospital of South Manchester in Manchester, UK.

His research interests include pre-invasive cancer (ductal carcinoma in situ), breast cancer stem cells, bone metastases, management of bone health and lymphoedema prevention. He is a Fellow of the Royal College of Surgeons of England. His research in Manchester was recognised by the Royal College of Surgeons when he was appointed to a Hunterian Professorship in 1995. He is a member of several medical societies and has been awarded numerous honours, as well as a National Institute for Health Research (NIHR) Senior Investigator Award. Prof. Bundred has authored or co-authored over 220 peer-reviewed articles published in many journals, including the Journal of the National Cancer Institute, The Lancet, Lancet Oncology, Cancer Research and Cancer.

He is Chief Investigator on several national clinical trials (including EPHOS-B ) and has published extensively on the biology and treatment of breast cancer. From 2007 until 2012 he was Greater Manchester National Cancer Research Network Lead and in 2012 became GM Clinical Research Network Director of Cancer Division.

He has been responsible for introducing several new innovative changes to patient care, including early discharge after surgery, sentinel node biopsy and genomic testing to predict therapy benefits. Prof. Bundred has been awarded an NIHR Programme Grant for £1.6m entitled "Individualising breast cancer treatment to improve survival and minimise complications."

Further Info»